// App-Quantinova.ai

: Exposure-response analysis of tezepelumab in patients with severe asthma to guide phase 3 dose selection

Researchers

Presenter

  • Neang Ly

Principal Investigators

  • Yanan Zheng

  • Janet M. Griffiths

  • Ren Van Der Merwe

  • Balaji Agoram

  • Lorin Roskos

Medical Centers

  • MedImmune, Mountain View, United States of America

  • MedImmune LLC, Gaithersburg, MD, United States of America

  • MedImmune, Cambridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Tezepelumab

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved